Atlas Trials

Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine

Clinical trial NCT02489929 · UNKNOWN

Trial details

NCT number
NCT02489929
Sponsor
Assistance Publique Hopitaux De Marseille
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Myeloid LeukemiaMyelodysplastic Syndromes
Start date
2015-08-01
Primary completion
2018-08-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.